Global Psychedelic Drugs Supply, Demand and Key Producers, 2024-2030

Description

The global Psychedelic Drugs market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report studies the global Psychedelic Drugs demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Psychedelic Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Psychedelic Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Psychedelic Drugs total market, 2019-2030, (USD Million)
Global Psychedelic Drugs total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Psychedelic Drugs total market, key domestic companies and share, (USD Million)
Global Psychedelic Drugs revenue by player and market share 2019-2024, (USD Million)
Global Psychedelic Drugs total market by Type, CAGR, 2019-2030, (USD Million)
Global Psychedelic Drugs total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Psychedelic Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include COMPASS Pathways PLC, Pfizer, Eli Lilly, GlaxoSmithKline, Cybin Inc, Field Trip Health, ATAI Life Sciences, NUMINUS WELLNESS and MindMed, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Psychedelic Drugs market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Psychedelic Drugs Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Psychedelic Drugs Market, Segmentation by Type
    Psilocybin
    LSD
    MDMA
    DMT
    Ketamine
    Others

Global Psychedelic Drugs Market, Segmentation by Application
    Depressive Disorders
    Post-Traumatic Stress Disorders
    Substance Abuse Disorders
    Obsessive Compulsive Disorders
    Others

Companies Profiled:
    COMPASS Pathways PLC
    Pfizer
    Eli Lilly
    GlaxoSmithKline
    Cybin Inc
    Field Trip Health
    ATAI Life Sciences
    NUMINUS WELLNESS
    MindMed
    HAVN Life Sciences
    Seelos Therapeutics
    Jannsen
    Acadia Pharmaceuticals
    Intellipharmaceutics
    Revive Therapeutics
    Mydecine Innovations Group
    Red Light Holland
    Braxia Scientific
    Mind Cure Health
    Entheon Biomedical

Key Questions Answered
1. How big is the global Psychedelic Drugs market?
2. What is the demand of the global Psychedelic Drugs market?
3. What is the year over year growth of the global Psychedelic Drugs market?
4. What is the total value of the global Psychedelic Drugs market?
5. Who are the major players in the global Psychedelic Drugs market?

Table of Contents

1 Supply Summary
    1.1 Psychedelic Drugs Introduction
    1.2 World Psychedelic Drugs Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Psychedelic Drugs Total Market by Region (by Headquarter Location)
        1.3.1 World Psychedelic Drugs Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Psychedelic Drugs Market Size (2019-2030)
        1.3.3 China Psychedelic Drugs Market Size (2019-2030)
        1.3.4 Europe Psychedelic Drugs Market Size (2019-2030)
        1.3.5 Japan Psychedelic Drugs Market Size (2019-2030)
        1.3.6 South Korea Psychedelic Drugs Market Size (2019-2030)
        1.3.7 ASEAN Psychedelic Drugs Market Size (2019-2030)
        1.3.8 India Psychedelic Drugs Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Psychedelic Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Psychedelic Drugs Major Market Trends

2 Demand Summary
    2.1 World Psychedelic Drugs Consumption Value (2019-2030)
    2.2 World Psychedelic Drugs Consumption Value by Region
        2.2.1 World Psychedelic Drugs Consumption Value by Region (2019-2024)
        2.2.2 World Psychedelic Drugs Consumption Value Forecast by Region (2025-2030)
    2.3 United States Psychedelic Drugs Consumption Value (2019-2030)
    2.4 China Psychedelic Drugs Consumption Value (2019-2030)
    2.5 Europe Psychedelic Drugs Consumption Value (2019-2030)
    2.6 Japan Psychedelic Drugs Consumption Value (2019-2030)
    2.7 South Korea Psychedelic Drugs Consumption Value (2019-2030)
    2.8 ASEAN Psychedelic Drugs Consumption Value (2019-2030)
    2.9 India Psychedelic Drugs Consumption Value (2019-2030)

3 World Psychedelic Drugs Companies Competitive Analysis
    3.1 World Psychedelic Drugs Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Psychedelic Drugs Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Psychedelic Drugs in 2023
        3.2.3 Global Concentration Ratios (CR8) for Psychedelic Drugs in 2023
    3.3 Psychedelic Drugs Company Evaluation Quadrant
    3.4 Psychedelic Drugs Market: Overall Company Footprint Analysis
        3.4.1 Psychedelic Drugs Market: Region Footprint
        3.4.2 Psychedelic Drugs Market: Company Product Type Footprint
        3.4.3 Psychedelic Drugs Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Psychedelic Drugs Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Psychedelic Drugs Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Psychedelic Drugs Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Psychedelic Drugs Consumption Value Comparison
        4.2.1 United States VS China: Psychedelic Drugs Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Psychedelic Drugs Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Psychedelic Drugs Companies and Market Share, 2019-2024
        4.3.1 United States Based Psychedelic Drugs Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Psychedelic Drugs Revenue, (2019-2024)
    4.4 China Based Companies Psychedelic Drugs Revenue and Market Share, 2019-2024
        4.4.1 China Based Psychedelic Drugs Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Psychedelic Drugs Revenue, (2019-2024)
    4.5 Rest of World Based Psychedelic Drugs Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Psychedelic Drugs Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Psychedelic Drugs Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Psychedelic Drugs Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Psilocybin
        5.2.2 LSD
        5.2.3 MDMA
        5.2.4 DMT
        5.2.5 Ketamine
        5.2.6 Others
    5.3 Market Segment by Type
        5.3.1 World Psychedelic Drugs Market Size by Type (2019-2024)
        5.3.2 World Psychedelic Drugs Market Size by Type (2025-2030)
        5.3.3 World Psychedelic Drugs Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Psychedelic Drugs Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Depressive Disorders
        6.2.2 Post-Traumatic Stress Disorders
        6.2.3 Substance Abuse Disorders
        6.2.4 Obsessive Compulsive Disorders
        6.2.5 Obsessive Compulsive Disorders
    6.3 Market Segment by Application
        6.3.1 World Psychedelic Drugs Market Size by Application (2019-2024)
        6.3.2 World Psychedelic Drugs Market Size by Application (2025-2030)
        6.3.3 World Psychedelic Drugs Market Size by Application (2019-2030)

7 Company Profiles
    7.1 COMPASS Pathways PLC
        7.1.1 COMPASS Pathways PLC Details
        7.1.2 COMPASS Pathways PLC Major Business
        7.1.3 COMPASS Pathways PLC Psychedelic Drugs Product and Services
        7.1.4 COMPASS Pathways PLC Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 COMPASS Pathways PLC Recent Developments/Updates
        7.1.6 COMPASS Pathways PLC Competitive Strengths & Weaknesses
    7.2 Pfizer
        7.2.1 Pfizer Details
        7.2.2 Pfizer Major Business
        7.2.3 Pfizer Psychedelic Drugs Product and Services
        7.2.4 Pfizer Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Pfizer Recent Developments/Updates
        7.2.6 Pfizer Competitive Strengths & Weaknesses
    7.3 Eli Lilly
        7.3.1 Eli Lilly Details
        7.3.2 Eli Lilly Major Business
        7.3.3 Eli Lilly Psychedelic Drugs Product and Services
        7.3.4 Eli Lilly Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Eli Lilly Recent Developments/Updates
        7.3.6 Eli Lilly Competitive Strengths & Weaknesses
    7.4 GlaxoSmithKline
        7.4.1 GlaxoSmithKline Details
        7.4.2 GlaxoSmithKline Major Business
        7.4.3 GlaxoSmithKline Psychedelic Drugs Product and Services
        7.4.4 GlaxoSmithKline Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 GlaxoSmithKline Recent Developments/Updates
        7.4.6 GlaxoSmithKline Competitive Strengths & Weaknesses
    7.5 Cybin Inc
        7.5.1 Cybin Inc Details
        7.5.2 Cybin Inc Major Business
        7.5.3 Cybin Inc Psychedelic Drugs Product and Services
        7.5.4 Cybin Inc Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Cybin Inc Recent Developments/Updates
        7.5.6 Cybin Inc Competitive Strengths & Weaknesses
    7.6 Field Trip Health
        7.6.1 Field Trip Health Details
        7.6.2 Field Trip Health Major Business
        7.6.3 Field Trip Health Psychedelic Drugs Product and Services
        7.6.4 Field Trip Health Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Field Trip Health Recent Developments/Updates
        7.6.6 Field Trip Health Competitive Strengths & Weaknesses
    7.7 ATAI Life Sciences
        7.7.1 ATAI Life Sciences Details
        7.7.2 ATAI Life Sciences Major Business
        7.7.3 ATAI Life Sciences Psychedelic Drugs Product and Services
        7.7.4 ATAI Life Sciences Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 ATAI Life Sciences Recent Developments/Updates
        7.7.6 ATAI Life Sciences Competitive Strengths & Weaknesses
    7.8 NUMINUS WELLNESS
        7.8.1 NUMINUS WELLNESS Details
        7.8.2 NUMINUS WELLNESS Major Business
        7.8.3 NUMINUS WELLNESS Psychedelic Drugs Product and Services
        7.8.4 NUMINUS WELLNESS Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 NUMINUS WELLNESS Recent Developments/Updates
        7.8.6 NUMINUS WELLNESS Competitive Strengths & Weaknesses
    7.9 MindMed
        7.9.1 MindMed Details
        7.9.2 MindMed Major Business
        7.9.3 MindMed Psychedelic Drugs Product and Services
        7.9.4 MindMed Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 MindMed Recent Developments/Updates
        7.9.6 MindMed Competitive Strengths & Weaknesses
    7.10 HAVN Life Sciences
        7.10.1 HAVN Life Sciences Details
        7.10.2 HAVN Life Sciences Major Business
        7.10.3 HAVN Life Sciences Psychedelic Drugs Product and Services
        7.10.4 HAVN Life Sciences Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 HAVN Life Sciences Recent Developments/Updates
        7.10.6 HAVN Life Sciences Competitive Strengths & Weaknesses
    7.11 Seelos Therapeutics
        7.11.1 Seelos Therapeutics Details
        7.11.2 Seelos Therapeutics Major Business
        7.11.3 Seelos Therapeutics Psychedelic Drugs Product and Services
        7.11.4 Seelos Therapeutics Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Seelos Therapeutics Recent Developments/Updates
        7.11.6 Seelos Therapeutics Competitive Strengths & Weaknesses
    7.12 Jannsen
        7.12.1 Jannsen Details
        7.12.2 Jannsen Major Business
        7.12.3 Jannsen Psychedelic Drugs Product and Services
        7.12.4 Jannsen Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 Jannsen Recent Developments/Updates
        7.12.6 Jannsen Competitive Strengths & Weaknesses
    7.13 Acadia Pharmaceuticals
        7.13.1 Acadia Pharmaceuticals Details
        7.13.2 Acadia Pharmaceuticals Major Business
        7.13.3 Acadia Pharmaceuticals Psychedelic Drugs Product and Services
        7.13.4 Acadia Pharmaceuticals Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Acadia Pharmaceuticals Recent Developments/Updates
        7.13.6 Acadia Pharmaceuticals Competitive Strengths & Weaknesses
    7.14 Intellipharmaceutics
        7.14.1 Intellipharmaceutics Details
        7.14.2 Intellipharmaceutics Major Business
        7.14.3 Intellipharmaceutics Psychedelic Drugs Product and Services
        7.14.4 Intellipharmaceutics Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 Intellipharmaceutics Recent Developments/Updates
        7.14.6 Intellipharmaceutics Competitive Strengths & Weaknesses
    7.15 Revive Therapeutics
        7.15.1 Revive Therapeutics Details
        7.15.2 Revive Therapeutics Major Business
        7.15.3 Revive Therapeutics Psychedelic Drugs Product and Services
        7.15.4 Revive Therapeutics Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.15.5 Revive Therapeutics Recent Developments/Updates
        7.15.6 Revive Therapeutics Competitive Strengths & Weaknesses
    7.16 Mydecine Innovations Group
        7.16.1 Mydecine Innovations Group Details
        7.16.2 Mydecine Innovations Group Major Business
        7.16.3 Mydecine Innovations Group Psychedelic Drugs Product and Services
        7.16.4 Mydecine Innovations Group Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.16.5 Mydecine Innovations Group Recent Developments/Updates
        7.16.6 Mydecine Innovations Group Competitive Strengths & Weaknesses
    7.17 Red Light Holland
        7.17.1 Red Light Holland Details
        7.17.2 Red Light Holland Major Business
        7.17.3 Red Light Holland Psychedelic Drugs Product and Services
        7.17.4 Red Light Holland Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.17.5 Red Light Holland Recent Developments/Updates
        7.17.6 Red Light Holland Competitive Strengths & Weaknesses
    7.18 Braxia Scientific
        7.18.1 Braxia Scientific Details
        7.18.2 Braxia Scientific Major Business
        7.18.3 Braxia Scientific Psychedelic Drugs Product and Services
        7.18.4 Braxia Scientific Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.18.5 Braxia Scientific Recent Developments/Updates
        7.18.6 Braxia Scientific Competitive Strengths & Weaknesses
    7.19 Mind Cure Health
        7.19.1 Mind Cure Health Details
        7.19.2 Mind Cure Health Major Business
        7.19.3 Mind Cure Health Psychedelic Drugs Product and Services
        7.19.4 Mind Cure Health Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.19.5 Mind Cure Health Recent Developments/Updates
        7.19.6 Mind Cure Health Competitive Strengths & Weaknesses
    7.20 Entheon Biomedical
        7.20.1 Entheon Biomedical Details
        7.20.2 Entheon Biomedical Major Business
        7.20.3 Entheon Biomedical Psychedelic Drugs Product and Services
        7.20.4 Entheon Biomedical Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.20.5 Entheon Biomedical Recent Developments/Updates
        7.20.6 Entheon Biomedical Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Psychedelic Drugs Industry Chain
    8.2 Psychedelic Drugs Upstream Analysis
    8.3 Psychedelic Drugs Midstream Analysis
    8.4 Psychedelic Drugs Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Psychedelic Drugs Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Psychedelic Drugs Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Psychedelic Drugs Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Psychedelic Drugs Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Psychedelic Drugs Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Psychedelic Drugs Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Psychedelic Drugs Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Psychedelic Drugs Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Psychedelic Drugs Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Psychedelic Drugs Players in 2023
    Table 12. World Psychedelic Drugs Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Psychedelic Drugs Company Evaluation Quadrant
    Table 14. Head Office of Key Psychedelic Drugs Player
    Table 15. Psychedelic Drugs Market: Company Product Type Footprint
    Table 16. Psychedelic Drugs Market: Company Product Application Footprint
    Table 17. Psychedelic Drugs Mergers & Acquisitions Activity
    Table 18. United States VS China Psychedelic Drugs Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Psychedelic Drugs Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Psychedelic Drugs Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Psychedelic Drugs Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Psychedelic Drugs Revenue Market Share (2019-2024)
    Table 23. China Based Psychedelic Drugs Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Psychedelic Drugs Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Psychedelic Drugs Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Psychedelic Drugs Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Psychedelic Drugs Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Psychedelic Drugs Revenue Market Share (2019-2024)
    Table 29. World Psychedelic Drugs Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Psychedelic Drugs Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Psychedelic Drugs Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Psychedelic Drugs Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Psychedelic Drugs Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Psychedelic Drugs Market Size by Application (2025-2030) & (USD Million)
    Table 35. COMPASS Pathways PLC Basic Information, Area Served and Competitors
    Table 36. COMPASS Pathways PLC Major Business
    Table 37. COMPASS Pathways PLC Psychedelic Drugs Product and Services
    Table 38. COMPASS Pathways PLC Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. COMPASS Pathways PLC Recent Developments/Updates
    Table 40. COMPASS Pathways PLC Competitive Strengths & Weaknesses
    Table 41. Pfizer Basic Information, Area Served and Competitors
    Table 42. Pfizer Major Business
    Table 43. Pfizer Psychedelic Drugs Product and Services
    Table 44. Pfizer Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Pfizer Recent Developments/Updates
    Table 46. Pfizer Competitive Strengths & Weaknesses
    Table 47. Eli Lilly Basic Information, Area Served and Competitors
    Table 48. Eli Lilly Major Business
    Table 49. Eli Lilly Psychedelic Drugs Product and Services
    Table 50. Eli Lilly Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Eli Lilly Recent Developments/Updates
    Table 52. Eli Lilly Competitive Strengths & Weaknesses
    Table 53. GlaxoSmithKline Basic Information, Area Served and Competitors
    Table 54. GlaxoSmithKline Major Business
    Table 55. GlaxoSmithKline Psychedelic Drugs Product and Services
    Table 56. GlaxoSmithKline Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. GlaxoSmithKline Recent Developments/Updates
    Table 58. GlaxoSmithKline Competitive Strengths & Weaknesses
    Table 59. Cybin Inc Basic Information, Area Served and Competitors
    Table 60. Cybin Inc Major Business
    Table 61. Cybin Inc Psychedelic Drugs Product and Services
    Table 62. Cybin Inc Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Cybin Inc Recent Developments/Updates
    Table 64. Cybin Inc Competitive Strengths & Weaknesses
    Table 65. Field Trip Health Basic Information, Area Served and Competitors
    Table 66. Field Trip Health Major Business
    Table 67. Field Trip Health Psychedelic Drugs Product and Services
    Table 68. Field Trip Health Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Field Trip Health Recent Developments/Updates
    Table 70. Field Trip Health Competitive Strengths & Weaknesses
    Table 71. ATAI Life Sciences Basic Information, Area Served and Competitors
    Table 72. ATAI Life Sciences Major Business
    Table 73. ATAI Life Sciences Psychedelic Drugs Product and Services
    Table 74. ATAI Life Sciences Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. ATAI Life Sciences Recent Developments/Updates
    Table 76. ATAI Life Sciences Competitive Strengths & Weaknesses
    Table 77. NUMINUS WELLNESS Basic Information, Area Served and Competitors
    Table 78. NUMINUS WELLNESS Major Business
    Table 79. NUMINUS WELLNESS Psychedelic Drugs Product and Services
    Table 80. NUMINUS WELLNESS Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. NUMINUS WELLNESS Recent Developments/Updates
    Table 82. NUMINUS WELLNESS Competitive Strengths & Weaknesses
    Table 83. MindMed Basic Information, Area Served and Competitors
    Table 84. MindMed Major Business
    Table 85. MindMed Psychedelic Drugs Product and Services
    Table 86. MindMed Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. MindMed Recent Developments/Updates
    Table 88. MindMed Competitive Strengths & Weaknesses
    Table 89. HAVN Life Sciences Basic Information, Area Served and Competitors
    Table 90. HAVN Life Sciences Major Business
    Table 91. HAVN Life Sciences Psychedelic Drugs Product and Services
    Table 92. HAVN Life Sciences Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. HAVN Life Sciences Recent Developments/Updates
    Table 94. HAVN Life Sciences Competitive Strengths & Weaknesses
    Table 95. Seelos Therapeutics Basic Information, Area Served and Competitors
    Table 96. Seelos Therapeutics Major Business
    Table 97. Seelos Therapeutics Psychedelic Drugs Product and Services
    Table 98. Seelos Therapeutics Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 99. Seelos Therapeutics Recent Developments/Updates
    Table 100. Seelos Therapeutics Competitive Strengths & Weaknesses
    Table 101. Jannsen Basic Information, Area Served and Competitors
    Table 102. Jannsen Major Business
    Table 103. Jannsen Psychedelic Drugs Product and Services
    Table 104. Jannsen Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 105. Jannsen Recent Developments/Updates
    Table 106. Jannsen Competitive Strengths & Weaknesses
    Table 107. Acadia Pharmaceuticals Basic Information, Area Served and Competitors
    Table 108. Acadia Pharmaceuticals Major Business
    Table 109. Acadia Pharmaceuticals Psychedelic Drugs Product and Services
    Table 110. Acadia Pharmaceuticals Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 111. Acadia Pharmaceuticals Recent Developments/Updates
    Table 112. Acadia Pharmaceuticals Competitive Strengths & Weaknesses
    Table 113. Intellipharmaceutics Basic Information, Area Served and Competitors
    Table 114. Intellipharmaceutics Major Business
    Table 115. Intellipharmaceutics Psychedelic Drugs Product and Services
    Table 116. Intellipharmaceutics Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 117. Intellipharmaceutics Recent Developments/Updates
    Table 118. Intellipharmaceutics Competitive Strengths & Weaknesses
    Table 119. Revive Therapeutics Basic Information, Area Served and Competitors
    Table 120. Revive Therapeutics Major Business
    Table 121. Revive Therapeutics Psychedelic Drugs Product and Services
    Table 122. Revive Therapeutics Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 123. Revive Therapeutics Recent Developments/Updates
    Table 124. Revive Therapeutics Competitive Strengths & Weaknesses
    Table 125. Mydecine Innovations Group Basic Information, Area Served and Competitors
    Table 126. Mydecine Innovations Group Major Business
    Table 127. Mydecine Innovations Group Psychedelic Drugs Product and Services
    Table 128. Mydecine Innovations Group Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 129. Mydecine Innovations Group Recent Developments/Updates
    Table 130. Mydecine Innovations Group Competitive Strengths & Weaknesses
    Table 131. Red Light Holland Basic Information, Area Served and Competitors
    Table 132. Red Light Holland Major Business
    Table 133. Red Light Holland Psychedelic Drugs Product and Services
    Table 134. Red Light Holland Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 135. Red Light Holland Recent Developments/Updates
    Table 136. Red Light Holland Competitive Strengths & Weaknesses
    Table 137. Braxia Scientific Basic Information, Area Served and Competitors
    Table 138. Braxia Scientific Major Business
    Table 139. Braxia Scientific Psychedelic Drugs Product and Services
    Table 140. Braxia Scientific Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 141. Braxia Scientific Recent Developments/Updates
    Table 142. Braxia Scientific Competitive Strengths & Weaknesses
    Table 143. Mind Cure Health Basic Information, Area Served and Competitors
    Table 144. Mind Cure Health Major Business
    Table 145. Mind Cure Health Psychedelic Drugs Product and Services
    Table 146. Mind Cure Health Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 147. Mind Cure Health Recent Developments/Updates
    Table 148. Entheon Biomedical Basic Information, Area Served and Competitors
    Table 149. Entheon Biomedical Major Business
    Table 150. Entheon Biomedical Psychedelic Drugs Product and Services
    Table 151. Entheon Biomedical Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 152. Global Key Players of Psychedelic Drugs Upstream (Raw Materials)
    Table 153. Psychedelic Drugs Typical Customers
List of Figure
    Figure 1. Psychedelic Drugs Picture
    Figure 2. World Psychedelic Drugs Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Psychedelic Drugs Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Psychedelic Drugs Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Psychedelic Drugs Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Psychedelic Drugs Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Psychedelic Drugs Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Psychedelic Drugs Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Psychedelic Drugs Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Psychedelic Drugs Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Psychedelic Drugs Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Psychedelic Drugs Revenue (2019-2030) & (USD Million)
    Figure 13. Psychedelic Drugs Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Psychedelic Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Psychedelic Drugs Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Psychedelic Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Psychedelic Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Psychedelic Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Psychedelic Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Psychedelic Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Psychedelic Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Psychedelic Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Psychedelic Drugs by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Psychedelic Drugs Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Psychedelic Drugs Markets in 2023
    Figure 27. United States VS China: Psychedelic Drugs Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Psychedelic Drugs Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Psychedelic Drugs Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Psychedelic Drugs Market Size Market Share by Type in 2023
    Figure 31. Psilocybin
    Figure 32. LSD
    Figure 33. MDMA
    Figure 34. DMT
    Figure 35. Ketamine
    Figure 36. Others
    Figure 37. World Psychedelic Drugs Market Size Market Share by Type (2019-2030)
    Figure 38. World Psychedelic Drugs Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 39. World Psychedelic Drugs Market Size Market Share by Application in 2023
    Figure 40. Depressive Disorders
    Figure 41. Post-Traumatic Stress Disorders
    Figure 42. Substance Abuse Disorders
    Figure 43. Obsessive Compulsive Disorders
    Figure 44. Others
    Figure 45. Psychedelic Drugs Industrial Chain
    Figure 46. Methodology
    Figure 47. Research Process and Data Source

Companies Mentioned

COMPASS Pathways PLC
Pfizer
Eli Lilly
GlaxoSmithKline
Cybin Inc
Field Trip Health
ATAI Life Sciences
NUMINUS WELLNESS
MindMed
HAVN Life Sciences
Seelos Therapeutics
Jannsen
Acadia Pharmaceuticals
Intellipharmaceutics
Revive Therapeutics
Mydecine Innovations Group
Red Light Holland
Braxia Scientific
Mind Cure Health
Entheon Biomedical